论文部分内容阅读
目的:对50例宫外孕保守治疗,观察其临床疗效。方法:选取本院2006年6月-2011年12月收治的符合本文入选要求的患者50例,肌内注射氨甲喋呤(MTX),0.5mg/(kg*日),7天为一个疗程,检测血β-HCG,观察其临床疗效及不良反应情况。结果:7天后,在50例宫外孕保守治疗患者中,24例治愈,17例患者显效,8例无效,1例恶心呕吐严重患者治疗3天后放弃保守治疗。半月后,又有4例显效,另4例无效选择其他治疗方案,1个月后复查患者血β-HCG,B超,除4例外其他治愈和显效46例患者疗效保持或好转,其保守治疗成功率为91.84%。三个月后再次检查无并发症发生。结论:MTX保守治疗宫外孕具有方法简便,成功率高,不良反应少的特点,值得临床推广。
Objective: To observe the clinical efficacy of 50 cases of conservative treatment of ectopic pregnancy. Methods: Fifty patients who met the criteria for this study were selected from June 2006 to December 2011 in our hospital. Methotrexate (MTX) was administered intramuscularly at a dose of 0.5 mg / (kg * day) for 7 days. The blood was tested for blood β-HCG, observe the clinical efficacy and adverse reactions. Results: Seven days later, among the 50 patients with conservative treatment of ectopic pregnancy, 24 were cured, 17 were markedly effective, and 8 were ineffective. One patient with severe nausea and vomiting discontinued conservative treatment after 3 days of treatment. Half a month later, another 4 cases markedly effective, and the other 4 cases were ineffective to choose other treatment options, 1 month after the review of blood β-HCG, B ultrasound, with the exception of 4 cases of other cured and markedly effective in 46 patients remain or improve the efficacy of its conservative treatment The success rate was 91.84%. After three months, check again for no complications. Conclusion: MTX conservative treatment of ectopic pregnancy with simple, high success rate, fewer adverse reactions, is worth clinical promotion.